Department of Medicine–

Mindie H. Nguyen, MD, MAS

Back to Profile

Publication Details

  • High frequency of recurrent viremia after hepatitis B e antigen seroconversion and consolidation therapy.

    Chaung KT, Ha NB, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Garcia G, Ahmed A, Keeffe EB, Nguyen MH. J Clin Gastroenterol. 2012 Nov-Dec; 46 (10): 865-70

    The primary treatment endpoint for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B is HBeAg seroconversion; however, data on the durability of response are inconsistent.

    PubMedID: 22941429

Stanford Medicine Resources:

Footer Links: